Title : Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization.

Pub. Date : 2018 Sep 21

PMID : 30248938






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low-dose naltrexone (LDN), considered in a daily dose of 1 to 5 mg, has been shown to reduce glial inflammatory response by modulating Toll-like receptor 4 signaling in addition to systemically upregulating endogenous opioid signaling by transient opioid-receptor blockade. Naltrexone toll like receptor 4 Homo sapiens